{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:57:37Z","timestamp":1791914257210,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,6,6]],"date-time":"2013-06-06T00:00:00Z","timestamp":1370476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,6,6]],"date-time":"2013-06-06T00:00:00Z","timestamp":1370476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1038\/jhh.2013.47","type":"journal-article","created":{"date-parts":[[2013,6,6]],"date-time":"2013-06-06T09:17:54Z","timestamp":1370510274000},"page":"10-14","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Calcium channel blocker-induced gingival enlargement"],"prefix":"10.1038","volume":"28","author":[{"given":"R","family":"Livada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Shiloah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,6,6]]},"reference":[{"key":"BFjhh201347_CR1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1113\/jphysiol.1953.sp004884","volume":"120","author":"P Fatt","year":"1953","unstructured":"Fatt P, Katz B . The electrical properties of crustacean muscle fibers. J Physiol 1953a; 120: 171\u2013204.","journal-title":"J Physiol"},{"key":"BFjhh201347_CR2","first-page":"13","volume":"52","author":"A Fleckenstein","year":"1983","unstructured":"Fleckenstein A . History of calcium antagonists. Circ Res 1983; 52: 13\u201316.","journal-title":"Circ Res"},{"key":"BFjhh201347_CR3","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1001\/jama.287.3.337","volume":"287","author":"DW Kaufman","year":"2002","unstructured":"Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA . Recent patterns of medication use in the ambulatory adult population of the United States: The Slone Survey. JAMA 2002; 287: 337\u2013344.","journal-title":"JAMA"},{"issue":"4","key":"BFjhh201347_CR4","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3109\/08037059609079672","volume":"5","author":"T Toyo-Oka","year":"1996","unstructured":"Toyo-Oka T, Nayler WG . Third generation calcium entry blockers. Blood Press 1996; 5 (4): 206\u2013208.","journal-title":"Blood Press"},{"issue":"2","key":"BFjhh201347_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2165\/00002018-199615020-00002","volume":"15","author":"HT Dougall","year":"1996","unstructured":"Dougall HT, McLay J . A comparative review of the adverse effects of calcium antagonists. Drug Saf 1996; 15 (2): 91\u2013106.","journal-title":"Drug Saf"},{"key":"BFjhh201347_CR6","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/0030-4220(90)90406-I","volume":"70","author":"RS Brown","year":"1990","unstructured":"Brown RS, Sein P, Corio R, Bottomley WK . Nitrendipine-induced gingival hyperplasia. Oral Surg Oral Med Oral Pathol 1990; 70: 593\u2013596.","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"BFjhh201347_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1600-0765.1990.tb00893.x","volume":"25","author":"A Nyska","year":"1990","unstructured":"Nyska A, Waner T, Pirak M, Galiano A, Zlotogorski A . Gingival hyperplasia in rats induced by oxodipine -a calcium channel blocker. J Periodontal Res 1990; 25: 65\u201368.","journal-title":"J Periodontal Res"},{"key":"BFjhh201347_CR8","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1902\/jop.1997.68.7.676","volume":"68","author":"MG Jorgensen","year":"1997","unstructured":"Jorgensen MG . Prevalence of amlodipine-related gingival hyperplasia. J Periodontol 1997; 68: 676\u2013678.","journal-title":"J Periodontol"},{"issue":"2","key":"BFjhh201347_CR9","first-page":"151","volume":"17","author":"Guidelines Subcommittee","year":"1999","unstructured":"Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension: Guidelines Subcommittee. J Hypertens 1999; 17 (2): 151\u2013183.","journal-title":"J Hypertens"},{"key":"BFjhh201347_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.14219\/jada.archive.1987.0050","volume":"114","author":"RT Butler","year":"1987","unstructured":"Butler RT, Kalkwarf KL, Kaldahl WB . Drug-induced gingival hyperplasia: phenytoin, cyclosporine, and nifedipine. J Am Dent Assoc 1987; 114: 56\u201360.","journal-title":"J Am Dent Assoc"},{"key":"BFjhh201347_CR11","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/0030-4220(84)90283-4","volume":"55","author":"D Lederman","year":"1984","unstructured":"Lederman D, Lumerman H, Reuben S, Freedman PD . Gingival hyperplasia associated with nifedipine therapy: Report of a case. Oral Surg Oral Med Oral Pathol 1984; 55: 620\u2013622.","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"BFjhh201347_CR12","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1902\/jop.1987.58.9.639","volume":"58","author":"S Barak","year":"1987","unstructured":"Barak S, Engelberg IS, Hiss J . Gingival hyperplasia caused by nifedipine. Histopathologic findings. J Periodontol 1987; 58: 639\u2013642.","journal-title":"J Periodontol"},{"key":"BFjhh201347_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1754-4505.1991.tb00828.x","volume":"11","author":"L Fattore","year":"1991","unstructured":"Fattore L, Stablein M, Bredfeldt G, Semla T, Moran M, Doherty-Greenberg JM . Gingival hyperplasia: a side effect of nifedipine and diltiazem. Spec Care Dent 1991; 11: 107\u2013109.","journal-title":"Spec Care Dent"},{"key":"BFjhh201347_CR14","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1902\/jop.1992.63.5.453","volume":"63","author":"CS Miller","year":"1992","unstructured":"Miller CS, Damm DD . Incidence of verapamil-induced gingival hyperplasia in a dental population. J Periodontol 1992; 63: 453\u2013456.","journal-title":"J Periodontol"},{"key":"BFjhh201347_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1600-0714.1991.tb00896.x","volume":"20","author":"T Lombardi","year":"1991","unstructured":"Lombardi T, Fiore-Donno G, Belser U, DiFelice R . Felodipine-induced gingival hyperplasia: a clinical and histologic study. J Oral Pathol Med 1991; 20: 89\u201392.","journal-title":"J Oral Pathol Med"},{"key":"BFjhh201347_CR16","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/sj.bdj.4807564","volume":"170","author":"RA Seymour","year":"1991","unstructured":"Seymour RA . Calcium channel blockers and gingival overgrowth. Br Dent J 1991; 170: 376.","journal-title":"Br Dent J"},{"key":"BFjhh201347_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1902\/jop.2002.73.1.115","volume":"73","author":"K Ikawa","year":"2002","unstructured":"Ikawa K, Ikawa M, Shimauchi H, Iwakura M, Sakamoto S . Treatment of gingival overgrowth induced by manidipine administration. A case report. J Periodontol 2002; 73: 115\u2013122.","journal-title":"J Periodontol"},{"key":"BFjhh201347_CR18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1600-0714.1991.tb00419.x","volume":"20","author":"RS Brown","year":"1991","unstructured":"Brown RS, Beaver WT, Bottomley WK . On the mechanism of drug-induced gingival hyperplasia. J Oral Pathol Med 1991; 20: 201\u2013209.","journal-title":"J Oral Pathol Med"},{"issue":"4","key":"BFjhh201347_CR19","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1902\/jop.1985.56.4.211","volume":"56","author":"RM Lucas","year":"1985","unstructured":"Lucas RM, Howell LP, Wall BA . Nifedipine-induced gingival hyperplasia. A histochemical and ultrastructural study. J Periodontol 1985; 56 (4): 211\u2013215.","journal-title":"J Periodontol"},{"key":"BFjhh201347_CR20","first-page":"116","volume":"21","author":"LH Silverstein","year":"1995","unstructured":"Silverstein LH, Koch JI, Lefkove MD, Garnick JJ, Singh B, Steflik DE . Nifedipine-induced gingival enlargement around dental implants: a clinical report. J Oral Implant 1995; 21: 116\u2013120.","journal-title":"J Oral Implant"},{"key":"BFjhh201347_CR21","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1834-7819.1999.tb00224.x","volume":"44","author":"RI Marshall","year":"1999","unstructured":"Marshall RI, Bartold PM . A clinical review of drug induced gingival overgrowth. Aust Dent J 1999; 44: 219\u2013232.","journal-title":"Aust Dent J"},{"key":"BFjhh201347_CR22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1600-051X.1992.tb00650.x","volume":"19","author":"S Barclay","year":"1992","unstructured":"Barclay S, Thomason JM, Idle JR, Seymour RA . The incidence and severity of nifedipine-induced gingival overgrowth. J Clin Periodontol 1992; 19: 311\u2013314.","journal-title":"J Clin Periodontol"},{"key":"BFjhh201347_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1034\/j.1600-0714.2000.290102.x","volume":"29","author":"RB Johnson","year":"2000","unstructured":"Johnson RB, Zebrowski EJ, Dai X . Synergistic enhancement of collagenous protein synthesis by human gingival fibroblasts exposed to nifedipine and interleukin- 1-beta in vitro. J Oral Pathol Med 2000; 29: 8\u201312.","journal-title":"J Oral Pathol Med"},{"key":"BFjhh201347_CR24","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1111\/1523-1747.ep12483971","volume":"97","author":"MR Duncan","year":"1991","unstructured":"Duncan MR, Berman B . Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin- 6. J Invest Dermatol 1991; 97: 686\u2013689.","journal-title":"J Invest Dermatol"},{"key":"BFjhh201347_CR25","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1097\/00007890-199457120-00022","volume":"57","author":"HE Pernu","year":"1994","unstructured":"Pernu HE, Knuuttila MLE, Huttenen KRH, Tiilikainen ASK . Drug-induced gingival overgrowth and class I1 major histocompatibility antigens. Transplantation 1994; 57: 1811\u20131813.","journal-title":"Transplantation"},{"key":"BFjhh201347_CR26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1034\/j.1600-051x.2000.027004217.x","volume":"27","author":"RA Seymour","year":"2000","unstructured":"Seymour RA, Ellis JS, Thomason JM . Risk factors for drug-induced gingival overgrowth. J Clin Periodontol 2000; 27: 217\u2013223.","journal-title":"J Clin Periodontol"},{"key":"BFjhh201347_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1902\/annals.1999.4.1.1","volume":"4","author":"GC Armitage","year":"1999","unstructured":"Armitage GC . Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999; 4: 1\u20136.","journal-title":"Ann Periodontol"},{"key":"BFjhh201347_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1902\/jop.1999.70.1.63","volume":"70","author":"J Ellis","year":"1999","unstructured":"Ellis J, Seymour R, Steele J, Robertson P, Butler T, Thomason JM . Prevalence of gingival overgrowth induced by calcium channel blockers: a community based study. J Periodontol 1999; 70: 63\u201367.","journal-title":"J Periodontol"},{"issue":"1","key":"BFjhh201347_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1600-0765.1990.tb01204.x","volume":"25","author":"M Sooriyamoorthy","year":"1990","unstructured":"Sooriyamoorthy M, Gower DB, Eley BM . Androgen metabolism in gingival hyperplasia induced by nifedipine and cyclosporin. J Periodont Res 1990; 25 (1): 25\u201330.","journal-title":"J Periodont Res"},{"key":"BFjhh201347_CR30","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1902\/jop.1995.66.5.345","volume":"66","author":"H Ishida","year":"1995","unstructured":"Ishida H, Kondoh T, Kataoka M, Nishikawa S, Nakagawa T, Morisaki I et al. Factors influencing nifedipineinduced gingival overgrowth in rats. J Periodontol 1995; 66: 345\u2013350.","journal-title":"J Periodontol"},{"key":"BFjhh201347_CR31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1177\/154411130401500104","volume":"15","author":"LA Torpet","year":"2004","unstructured":"Torpet LA, Kragelund C, Reibel J, Nauntofte B . Oral adverse drug reactions to cardiovascular drugs. Crit Rev Oral Biol Med 2004; 15: 28\u201346.","journal-title":"Crit Rev Oral Biol Med"},{"key":"BFjhh201347_CR32","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1902\/jop.1997.68.7.645","volume":"68","author":"P Westbrook","year":"1997","unstructured":"Westbrook P, Bednarczyk E, Carlson M, Sheehan H, Bissada N . Regression of nifedipine-induced gingival hyperplasia following switch to a same class calcium channel blocker, isradipine. J Periodontol 1997; 68: 645\u2013650.","journal-title":"J Periodontol"},{"key":"BFjhh201347_CR33","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1600-051X.2006.00930.x","volume":"33","author":"M Mavrogiannis","year":"2006","unstructured":"Mavrogiannis M, Ellis JS, Thomason JM, Seymour RA . The management of drug induced gingival overgrowth. J Clin Periodontol 2006; 33: 434\u2013439.","journal-title":"J Clin Periodontol"},{"key":"BFjhh201347_CR34","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1902\/jop.1999.70.9.967","volume":"70","author":"T Ilgenli","year":"1999","unstructured":"Ilgenli T, Atilla G, Baylas H . Effectiveness of periodontal therapy in patients with drug induced gingival overgrowth. Long\u2014term results. J Periodontol 1999; 70: 967\u2013972.","journal-title":"J Periodontol"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/jhh201347.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jhh201347","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jhh201347.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T16:45:11Z","timestamp":1647535511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jhh201347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,6]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["BFjhh201347"],"URL":"https:\/\/doi.org\/10.1038\/jhh.2013.47","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,6]]},"assertion":[{"value":"23 April 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}